Literature DB >> 7590569

Surgical treatment and prognostic variables of hepatocellular carcinoma in 122 cirrhotics.

V Di Carlo1, G Ferrari, R Castoldi, S Nadalin, C Marenghi, B Molteni, G Taccagni, M Castrucci.   

Abstract

A 10-year experience in surgical treatment of HCC in 122 cirrhotic patients has been reviewed in order to evaluate: perioperative mortality and morbidity, survival rates and prognostic variables by multiple-logistic analysis. Mortality rate declined from 7% in period 1983-88 to 2% in period 1989-92. Operative complications also decreased from 46% to 30%. The 3-year and 5-year overall survival rates were 42.6% and 23.3%. The 3-year and 5-year survival of patients who died only for HCC was 51.1% and 34.2% and the disease-free survival 30.6% and 19.1%. The good results of overall survival were vanished by the high rate of recurrence (19.1%). Multiple logistic regression analysis for the probability of mortality was significant for satellite nodules (RR 2.437), microvascular infiltration (RR 2.432), tumor size (RR 1.147); the model for the probability of recurrence was significant for microvascular infiltration (RR 2.290), satellite nodules (RR 2.280), lesions number (RR 2.216) and tumor size (RR 1.247).

Entities:  

Mesh:

Year:  1995        PMID: 7590569

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  12 in total

1.  Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Shoji Kubo; Kazuhiro Hirohashi; Osamu Yamazaki; Mitsuharu Matsuyama; Hiromu Tanaka; Katsuhiko Horii; Taichi Shuto; Takatsugu Yamamoto; Shuichi Kawai; Kenichi Wakasa; Shuhei Nishiguchi; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

2.  High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis.

Authors:  Ae Lyoung Min; Jong Young Choi; Hyun Young Woo; Jin Dong Kim; Jung Hyun Kwon; Si Hyun Bae; Seung Kew Yoon; Seung Hun Shin; Yeun Jun Chung; Chan Kwon Jung
Journal:  Clin Exp Metastasis       Date:  2009-06-16       Impact factor: 5.150

3.  Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.

Authors:  E Kouroumalis; P Skordilis; K Thermos; A Vasilaki; J Moschandrea; O N Manousos
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

4.  Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis.

Authors:  Pierre-Alain Clavien; Koo Jeong Kang; Nazia Selzner; Michael A Morse; Paul V Suhocki
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

Review 5.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Authors:  R Tung-Ping Poon; S T Fan; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

6.  Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.

Authors:  G Otto; U Heuschen; W J Hofmann; G Krumm; U Hinz; C Herfarth
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

7.  Risk factors for residual tumor after resection of hepatocellular carcinoma.

Authors:  Xiao-Hong Chen; Bo-Heng Zhang; Yin Xin; Zheng-Gang Ren; Jia Fan; Shuang-Jian Qiu; Jian Zhou
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

8.  Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy.

Authors:  Xiao-Ming Wang; Zhen-Yu Yin; Ren-Xiang Yu; You-Yuan Peng; Ping-Guo Liu; Guo-Yang Wu
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

9.  Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.

Authors:  Masaharu Hata; Koichi Tokuuye; Shinji Sugahara; Nobuyoshi Fukumitsu; Takayuki Hashimoto; Kayoko Ohnishi; Keiko Nemoto; Kiyoshi Ohara; Yasushi Matsuzaki; Yasuyuki Akine
Journal:  Strahlenther Onkol       Date:  2006-12       Impact factor: 3.621

10.  Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.

Authors:  S Kubo; S Nishiguchi; T Shuto; H Tanaka; T Tsukamoto; K Hirohashi; T Ikebe; K Wakasa; T Kuroki; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  1999-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.